STAT

APRIL 4, 2024

government agency tasked with ensuring the safe use of radioactive materials issued a recent report that the agency’s advisers had key undisclosed conflicts of interest, raising fresh concerns about controversial decisions around the reporting of radioactive injection accidents. The oversight division of a U.S.

332

332

STAT

DECEMBER 11, 2023

The medical device lobby also announced the creation of a new division focused on policy issues for medical imaging technology. AdvaMed named Peter Arduini, CEO of GE HealthCare, chair of its board of directors on Monday. The announcement formalizes his position, which he will serve in for two years.

294

294

STAT

MARCH 7, 2024

Forty years of affirmative action policies were unable to compensate for the devastating impact of the 1910 Flexner Report, which led to the mass closure of medical schools that admitted Black students, and an estimated loss of 35,000 Black physicians into the field. But the truth is more complicated than that. Read the rest…

Medical Schools 363

Medical Schools 363

STAT

APRIL 18, 2024

The about-face illustrates the difficulty the biotech industry faces in dealing with an issue that, fueled by national security concerns, is moving fast and forcefully. It also tests the ability of Crowley, who lacks a background in politics, to navigate a domestic policy issue that is tangled up in U.S.-China China relations.

276

276

STAT

JUNE 22, 2023

Doctors’ lobbyists in Washington tend to focus their energies on ensuring Medicare pays well, and on issues like so-called scope of practice laws. Whether from their lobbying or others, that first policy only forced researchers to make their work free after 12 months.

229

229

STAT

JULY 12, 2023

LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. The commission called Illumina’s actions “an unprecedented and very serious infringement” of the EU’s policies, including the “cornerstone” that regulators review deals that can alter the market.

241

241

STAT

AUGUST 1, 2023

Three large and growing physician groups backed by the private equity giant Welsh, Carson, Anderson & Stowe have hired a prominent lobbying firm to influence federal policy covering mergers and acquisitions. Over the past two weeks, United Musculoskeletal Partners, U.S. Anesthesia Partners, and U.S. Forbes Tate also did not respond.

Hospitals 246

Hospitals 246

STAT

MAY 13, 2024

The World Health Organization’s Intergovernmental Negotiating Body failed to reach consensus on a pandemic agreement last Friday, the last scheduled day of negotiations before the upcoming World Health Assembly , Health Policy Watch says.

Diabetes 258

Diabetes 258

STAT

NOVEMBER 7, 2023

The move comes two months after the FTC issued a policy statement noting some drug companies have failed to follow requirements for listing patents in the Food and Drug Administration’s Orange Book in hopes of thwarting competition from lower-cost generic medicines.

Generic Medicine 312

Generic Medicine 312

STAT

FEBRUARY 17, 2023

In December, he was named chairman of a new 12-person congressional commission tasked with issuing a set of policy recommendations for how the U.S. This year, Kelly will have a chance to advocate more formally. government can keep the country’s biotech industry competitive and capable of serving national security needs.

246

246

STAT

SEPTEMBER 1, 2022

An expert committee that advises the Centers for Disease Control and Prevention on vaccine policy voted on Thursday to recommend use of updated Covid-19 vaccines. With the positive votes from the Advisory Committee on Immunization Practices, the issue now goes to CDC Director Rochelle Walensky.

Vaccines 246

Vaccines Immunity Immunization 246

STAT

JANUARY 6, 2023

In Nebraska, the state’s inspector general of corrections requested that the prison explain a policy, obtained by STAT, requiring that incarcerated people sign a consent form that misrepresents the benefits of available hepatitis C treatments. Lawmakers in other states are pledging broader probes into the issue, too.

269

269

STAT

AUGUST 30, 2023

At issue is the cost of bedaquiline, which is the backbone of different combination therapies used to treat multi-drug-resistant tuberculosis. But advocacy groups continue to argue that Johnson & Johnson, which makes the pill, has stymied wider access.

Drug Pricing 337

Drug Pricing 337

STAT

APRIL 12, 2023

The White House on Wednesday issued an unprecedented warning about xylazine , the veterinary tranquilizer increasingly found in the illicit opioid supply. Beginning today, the substance will be classified as an “emerging drug threat” — the first designation of its kind.

244

244

STAT

JULY 27, 2023

To narrow the nation’s deeply entrenched health disparities, a permanent entity with regulatory powers should be created by the president to oversee health equity efforts across the entire federal government, says a report issued Thursday by the National Academies of Science, Engineering, and Medicine.

246

246

STAT

MARCH 14, 2023

At issue is the NRC’s policy that exempts practitioners of nuclear medicine — clinicians who use radioactive pharmaceuticals to diagnose or treat disease — from having to report when they mistakenly inject radiopharmaceuticals into a patient’s tissue rather than into a vein as intended.

246

246

STAT

SEPTEMBER 20, 2023

The policy would phase out patents and regulatory exclusivities and, in place of intellectual property protections, the U.S. A measure was passed directing the National Academies of Sciences, Engineering, and Medicine to study the idea and was added to the Pandemic and All-Hazards Preparedness Act. So, why prizes and not patents?

Drug Pricing 351

Drug Pricing 351

STAT

AUGUST 11, 2023

WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies.

Chemotherapy 246

Chemotherapy Hospitals 246

STAT

DECEMBER 20, 2022

But McDonald’s never followed through with specific details, other than issuing policy statements saying the medicines would not be used to promote the growth of food-producing livestock or for preventing disease in the animals. Continue to STAT+ to read the full story…

246

246

STAT

AUGUST 3, 2023

Medicare’s policies are creating obstacles that make it more difficult for patients who are highly likely to benefit to obtain access to diagnosis and treatment. There is an opportunity to lead on this important issue as new tools enable us to transform aging.

246

246

STAT

JUNE 22, 2023

Hope you have a smashing day and, of course, do stay in touch … Leaders of European pharmaceutical companies argued that a proposed overhaul of European Union policies could render the industry less competitive, the latest step in their opposition to legislation that could shorten exclusivity periods for selling drugs, STAT writes.

Diabetes 246

Diabetes Pharmaceutical Companies Pharmaceutical Companies Vaccines 246

Safe Biologics

DECEMBER 1, 2023

Visitors to the booth learned about ASBM’s recent educational activities surrounding IRA Medicare drug price negotiation, interchangeable biosimilars, and other key policy issues affecting patient access to medicines. Learn more about ACR Convergence 2023 here.

Drug Pricing 100

Drug Pricing Biosimilars 100

PhRMA

MAY 1, 2023

While policy debates about how to address these issues can seem never ending, American adults largely agree on what state policymakers should be doing to help deliver relief to patients at the pharmacy counter. Too many Americans are struggling to access and afford their health care.

117

117

STAT

MARCH 4, 2024

The judge decided AstraZeneca had not proved the program jeopardizes its constitutional property rights, and that the company did not have standing to challenge the guidance Medicare issued to implement the program. The case is the first of several filed by the pharmaceutical industry and its allies to be decided at the district court level.

Drug Pricing 275

Drug Pricing Labelling 275

Putting Patients First Blog

SEPTEMBER 22, 2023

By contextualizing the patient within social, economic, and environmental factors, health professionals can better provide robust programs while policy makers implement policies to assist in food accessibility.

Diabetes 106

Diabetes 106

Safe Biologics

MAY 15, 2023

On May 15th, ASBM Executive Director Michael Reilly participated in a webinar entitled Impact of Emerging Policies on the Vision of Older Canadians hosted by the International Federation on Ageing (IFA).

Biosimilars 130

Biosimilars 130

Safe Biologics

MAY 15, 2023

On May 15th, ASBM Executive Director Michael Reilly participated in a webinar entitled Impact of Emerging Policies on the Vision of Older Canadians hosted by the International Federation on Ageing (IFA).

Biosimilars 130

Biosimilars 130

STAT

DECEMBER 7, 2023

The administration will issue a framework for the U.S. National Institutes of Health to more broadly use march-in rights, a policy that allows it to seize patents from drugmakers whose products rely on federally funded research.

Drug Pricing 268

Drug Pricing 268

Express Pharma

MARCH 21, 2024

Jain will oversee policy advocacy with the government across various sectors including solar, wellness, hospitality, pharmaceuticals, and others. Suyash Agrawal, Director of Krishna Multimedia, will assume the position of the new Vice-President of the CII Uttarakhand State Council.

Hospitals 104

Hospitals 104

Safe Biologics

DECEMBER 8, 2023

The webinar was the fourth in a series covering key health policy issues. On November 30, ASBM and the Generics and Biosimilars Initiative (GaBI) hosted I nterchangeable Designation for Biosimilars- Ensuring Continuity of Patient Care: Upholding Interchangeability Status for Biosimilars.

Biosimilars 130

Biosimilars Drug Pricing 130

European Pharmaceutical Review

MAY 9, 2024

For instance, identifying what regulations or guidance needs amendment or the potential need for new such policies or rules.

Communication 67

Communication 67

FDA Law Blog: Biosimilars

OCTOBER 5, 2023

Walsh — DOJ has issued another “voluntary disclosure” policy intended to encourage companies to disclose misconduct it discovers as part of a merger and acquisition. This new policy only applies to the disclosure of criminal conduct, not administrative or regulatory violations.

59

59

STAT

OCTOBER 5, 2023

The committee has jurisdiction over Medicare and Medicaid payment policies for hospitals. The panel is tentatively aiming to hold a hearing on the issue in November and has also started accepting input from outside stakeholders. Senate Finance Chair Ron Wyden (D-Ore.)

Dosage 268

Dosage Packaging Diabetes Hospitals 268

Putting Patients First Blog

DECEMBER 20, 2023

ET Event Location: Virtual The Government Relations Action Team meeting (formerly MIAT and HCRAT) will serve as the central forum for NHC policy and government relations professionals to get updates and provide input into the full array of patient-related policy issues on which the NHC and its members are focused.

52

52

Putting Patients First Blog

DECEMBER 20, 2023

ET Event Location: Virtual The Government Relations Action Team meeting (formerly MIAT and HCRAT) will serve as the central forum for NHC policy and government relations professionals to get updates and provide input into the full array of patient-related policy issues on which the NHC and its members are focused.

52

52

STAT

JULY 12, 2023

The European Union issued an antitrust fine of $475 million to Illumina, the genetic sequencing company, for closing its acquisition of Grail, a cancer detection company, before clearing it with regulators , STAT writes.  The  Illumina said it would appeal the decision. Continue to STAT+ to read the full story…

Hospitals 246

Hospitals 246

Putting Patients First Blog

JUNE 2, 2023

ET Event Location: Top of the Hill Banquet & Conference Center, Washington DC The Washington Representatives Summer Meeting will bring together leading government relations and policy professionals from the NHC’s member patient advocacy and other health nonprofit organizations. To become a sponsor, please contact Mary Crowther.

97

97